Andrew Paine

Work Performance Price Targets & Ratings Chart

Analyst Andrew Paine works at CLSA

Most recent stock forecast was given on RMD, ResMed at 19-Apr-2024.

Wall Street Analyst Andrew Paine

Analyst best performing recommendations are on RMD (RESMED).
RMD ResMed

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

224

$36.24 (19.30%)

215

18 days ago

5/7 (71.43%)

$34.68 (18.32%)

371

Buy

215

$27.24 (14.51%)

215

23 days ago

7/11 (63.64%)

$18.67 (9.51%)

66

Buy

205

$17.24 (9.18%)

185

2 months 20 days ago

5/11 (45.45%)

$14.1 (7.39%)

88

164

$-23.76 (-12.65%)

158

2 months 25 days ago

4/6 (66.67%)

$-21.88 (-11.77%)

30

Buy

207

$19.24 (10.25%)

2 months 25 days ago

4/5 (80%)

$21.12 (11.36%)

60

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?